JP2012521769A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012521769A5 JP2012521769A5 JP2012502309A JP2012502309A JP2012521769A5 JP 2012521769 A5 JP2012521769 A5 JP 2012521769A5 JP 2012502309 A JP2012502309 A JP 2012502309A JP 2012502309 A JP2012502309 A JP 2012502309A JP 2012521769 A5 JP2012521769 A5 JP 2012521769A5
- Authority
- JP
- Japan
- Prior art keywords
- tumor
- cells
- cell population
- initiating
- isolated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004027 cell Anatomy 0.000 claims 34
- 210000005102 tumor initiating cell Anatomy 0.000 claims 22
- 206010028980 Neoplasm Diseases 0.000 claims 18
- 210000004881 tumor cell Anatomy 0.000 claims 17
- 239000003795 chemical substances by application Substances 0.000 claims 10
- 238000000034 method Methods 0.000 claims 10
- 231100001221 nontumorigenic Toxicity 0.000 claims 9
- 101000884271 Homo sapiens Signal transducer CD24 Proteins 0.000 claims 5
- 102100038081 Signal transducer CD24 Human genes 0.000 claims 5
- 239000002246 antineoplastic agent Substances 0.000 claims 4
- 229940041181 antineoplastic drug Drugs 0.000 claims 4
- 102100032912 CD44 antigen Human genes 0.000 claims 3
- 101000868273 Homo sapiens CD44 antigen Proteins 0.000 claims 3
- 230000000779 depleting effect Effects 0.000 claims 2
- 208000020816 lung neoplasm Diseases 0.000 claims 2
- 230000005012 migration Effects 0.000 claims 2
- 238000013508 migration Methods 0.000 claims 2
- 231100000588 tumorigenic Toxicity 0.000 claims 2
- 230000000381 tumorigenic effect Effects 0.000 claims 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- 230000004069 differentiation Effects 0.000 claims 1
- 238000000684 flow cytometry Methods 0.000 claims 1
- 238000001943 fluorescence-activated cell sorting Methods 0.000 claims 1
- 230000000977 initiatory effect Effects 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 208000037841 lung tumor Diseases 0.000 claims 1
- 239000003550 marker Substances 0.000 claims 1
- 231100000590 oncogenic Toxicity 0.000 claims 1
- 230000002246 oncogenic effect Effects 0.000 claims 1
- 238000004091 panning Methods 0.000 claims 1
- 238000000926 separation method Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16427209P | 2009-03-27 | 2009-03-27 | |
| US61/164,272 | 2009-03-27 | ||
| PCT/US2010/028926 WO2010111659A1 (en) | 2009-03-27 | 2010-03-26 | Tumor-initiating cells and methods for using same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012521769A JP2012521769A (ja) | 2012-09-20 |
| JP2012521769A5 true JP2012521769A5 (cg-RX-API-DMAC7.html) | 2013-05-23 |
| JP5788863B2 JP5788863B2 (ja) | 2015-10-07 |
Family
ID=42332716
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012502309A Expired - Fee Related JP5788863B2 (ja) | 2009-03-27 | 2010-03-26 | 腫瘍開始細胞およびその使用方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US9340774B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2411508B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5788863B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2754610C (cg-RX-API-DMAC7.html) |
| ES (1) | ES2405605T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2010111659A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE031017T2 (en) | 2011-04-01 | 2017-06-28 | Wyeth Llc | Antibody Drug Conjugates |
| WO2013068874A1 (en) | 2011-11-11 | 2013-05-16 | Pfizer Inc. | Antibody-drug conjugates |
| US10254286B2 (en) | 2012-01-24 | 2019-04-09 | Pfizer Inc. | Methods for detecting 5T4-positive circulating tumor cells and methods of diagnosis of 5T4-positive cancer in a mammalian subject |
| WO2013148147A1 (en) | 2012-03-26 | 2013-10-03 | The U.S.A., As Represented By The Secretary Dept. Of Health And Human Services | Dna methylation analysis for the diagnosis, prognosis and treatment of adrenal neoplasms |
| US9551036B2 (en) * | 2013-02-25 | 2017-01-24 | Whitehead Institute For Biomedical Research | Metabolic gene mesenchymal signatures and uses thereof |
| WO2016022939A1 (en) * | 2014-08-08 | 2016-02-11 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Human monoclonal antibodies specific for 5t4 and methods of their use |
| US9476100B1 (en) * | 2015-07-06 | 2016-10-25 | Nucleix Ltd. | Methods for diagnosing bladder cancer |
| KR20190105028A (ko) | 2017-01-04 | 2019-09-11 | 내셔널 타이완 유니버시티 | 폐암 줄기 세포를 위한 바이오마커 |
| EP3595705A1 (en) * | 2017-03-15 | 2020-01-22 | Oxford BioMedica (UK) Limited | Method |
| CA3078791A1 (en) | 2017-10-11 | 2019-04-18 | Lunella Biotech, Inc. | Anti-mitochondrial inhibitors for oncogenic ras and myc |
| US11189361B2 (en) | 2018-06-28 | 2021-11-30 | International Business Machines Corporation | Functional analysis of time-series phylogenetic tumor evolution tree |
| US11211148B2 (en) | 2018-06-28 | 2021-12-28 | International Business Machines Corporation | Time-series phylogenetic tumor evolution trees |
| IL265451B (en) | 2019-03-18 | 2020-01-30 | Frumkin Dan | Methods and systems for the detection of methylation changes in DNA samples |
| CN114487418A (zh) | 2022-02-17 | 2022-05-13 | 温州医科大学附属第二医院(温州医科大学附属育英儿童医院) | TGFb RIII蛋白作为胃癌血清生物标志物的应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5869053A (en) | 1988-03-04 | 1999-02-09 | Cancer Research Campaign Technology, Ltd. | 5T4 antigen from human trophoblasts |
| DE68923027D1 (de) | 1988-03-04 | 1995-07-20 | Cancer Res Campaign Tech | Antigene. |
| US5736396A (en) | 1995-01-24 | 1998-04-07 | Case Western Reserve University | Lineage-directed induction of human mesenchymal stem cell differentiation |
| US7700359B2 (en) * | 2000-06-02 | 2010-04-20 | Novartis Vaccines And Diagnostics, Inc. | Gene products differentially expressed in cancerous cells |
| GB0215287D0 (en) * | 2002-07-02 | 2002-08-14 | Oxford Biomedica Ltd | 5T4 antigen expression |
| CA2578131A1 (en) | 2004-09-10 | 2006-03-23 | Wyeth | Humanized anti-5t4 antibodies and anti-5t4 antibody/calicheamicin conjugates |
| EP1945754B1 (en) | 2005-10-31 | 2014-07-23 | The Regents Of The University Of Michigan | Compositions and methods for treating and diagnosing cancer |
| SG170091A1 (en) | 2006-03-10 | 2011-04-29 | Wyeth Corp | Anti-5t4 antibodies and uses thereof |
-
2010
- 2010-03-26 US US13/260,459 patent/US9340774B2/en not_active Expired - Fee Related
- 2010-03-26 CA CA2754610A patent/CA2754610C/en not_active Expired - Fee Related
- 2010-03-26 EP EP10723417A patent/EP2411508B1/en not_active Not-in-force
- 2010-03-26 JP JP2012502309A patent/JP5788863B2/ja not_active Expired - Fee Related
- 2010-03-26 ES ES10723417T patent/ES2405605T3/es active Active
- 2010-03-26 WO PCT/US2010/028926 patent/WO2010111659A1/en not_active Ceased
-
2016
- 2016-04-14 US US15/098,915 patent/US20160326496A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Tang et al. | Exosomes: Emerging biomarkers and targets for ovarian cancer | |
| Nakata et al. | Contribution of neuroblastoma-derived exosomes to the production of pro-tumorigenic signals by bone marrow mesenchymal stromal cells | |
| EP3009454A3 (en) | Antibodies specific to cadherin-17 | |
| MX2009003306A (es) | Anticuerpos humanos que se unen a cxcr4 y sus usos. | |
| WO2016081748A3 (en) | Antibodies against cd73 and uses thereof | |
| Wu et al. | Extracellular vesicles in urologic malignancies—Implementations for future cancer care | |
| CL2012002700A1 (es) | Anticuerpo humanizado capaz de logarse especificamente a receptores de quimioquina 4 (cxcr4); molecula de acido nucleico aislada que codifica dicho anticuerpo; vector y célula que comprenden dicho acido nucleico; composicion que comprende dicho anticuerpo; proceso de deteccion in vitro de la presencia y/o la ubicacion de un tumor que expresa cxcr4. | |
| US10081793B2 (en) | Method for separating cells using immunorosettes and magnetic particles | |
| RU2013124412A (ru) | Покрытые графеном алмазные частицы, композиции и промежуточные структуры, содержащие такие частицы, и способы формирования покрытых графеном алмазных частиц и поликристаллических элементов | |
| AR095980A1 (es) | Anticuerpos biespecíficos específicos para fap (proteína de activación fibroblástica) y dr5 (receptor de muerte 5), anticuerpos específicos para dr5 y métodos de utilización | |
| WO2012054084A3 (en) | Antibodies | |
| PL2313201T3 (pl) | Selektywne rozdzielanie materiałów za pomocą zmodyfikowanych cząstek magnetycznych | |
| JP2015506926A5 (cg-RX-API-DMAC7.html) | ||
| IN2012DN00834A (cg-RX-API-DMAC7.html) | ||
| MX2009005776A (es) | Anticuerpos humanos que se enlazan al cd 22 y sus usos. | |
| JP2017536114A5 (cg-RX-API-DMAC7.html) | ||
| CN103436493B (zh) | 雷帕霉素诱导调节性γδT细胞的培养方法 | |
| MX2022007613A (es) | Union de anticuerpos de cadena pesada a cd38. | |
| UA102891C2 (uk) | Повні людські антитіла, специфічні до cadm1 | |
| CN114174829A (zh) | T细胞受体的选择 | |
| AR089028A1 (es) | Composiciones y metodos para el analisis de cancer de prostata | |
| Soltanian et al. | Kaempferol and docetaxel diminish side population and down-regulate some cancer stem cell markers in breast cancer cell line MCF-7 | |
| EA201400065A1 (ru) | Антитела | |
| CN108398560A (zh) | 一种cd133质谱流式抗体、制备方法及应用 | |
| BR112015014270A2 (pt) | co-diferenciação de monócitos a partir de doadores alogênicos |